MedTrace Logo

Wound Healing Following Penile Prosthesis Implant

NCT05196191 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-03-01

No results posted yet for this study

Summary

This is a prospective, randomized, clinical study aimed to evaluate the safety and efficacy of the two treatment schedules on men undergoing penile implant surgery for the first time. The patients are randomized in a 2:1 ratio of active to sham treatment groups.

Conditions

Interventions

BIOLOGICAL

VIAGENEX Max

Collagenous membrane derived from umbilical cord

PROCEDURE

Hibiclens wash

Antiseptic skin cleanser

Sponsors & Collaborators

  • VIVEX Biologics, Inc.

    lead INDUSTRY

Principal Investigators

  • Tariq Hakky, MD · Atlanta Cosmetic Urology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-01-03
Primary Completion
2023-12-13
Completion
2023-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05196191 on ClinicalTrials.gov